Biothea Pharma, Inc. — Form D

Biothea Pharma, Inc. of Boston, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-08-06. The offering totals $22.0M, of which $22.0M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2021-08-06
• Form: D
• Accession: 0001567619-21-014627
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $22.0M
• Amount sold: $22.0M
• Investors: 30
• Date of first sale: 2021-07-23
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-409135

Issuer

• Name: Biothea Pharma, Inc.
• CIK: 0001877163
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 125 Summer Street, Boston, MA, 02110
• Phone: (857) 284-8876

Officers, directors & promoters (7)

More

• CIK 1877163 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search